Medvantx
Jen (Jennifer) Buist has a diverse work experience in various industries. Jen (Jennifer) is currently working as the Director of Quality and Compliance at Medvantx since May 2022. Before that, they served as the Manager of Regulatory Compliance Audit Readiness at Centene Corporation from November 2019 to May 2022. Prior to that, they worked as the Manager of Compliance Reporting at Lumeris from January 2018 to November 2019. Jen also has experience working as the Senior Manager of Government Programs & Investigations at Express Scripts from February 2016 to December 2017. Jen (Jennifer) has worked as a Senior Data Analyst in Controlled Substances Compliance at Mallinckrodt Pharmaceuticals from December 2011 to February 2016. Before that, they served as an In-Process Quality Engineer II at Covidien from November 2007 to December 2011. Jen also has experience as an Owner at JMW Contract Services from November 2006 to February 2008, and as a Planner/Scheduler/ALM Interface at Pfizer from March 2007 to November 2007. Jen (Jennifer) has worked as a DEA Compliance Officer/Quality Assurance Manager at Legacy Pharmaceutical Packaging from April 2004 to November 2006, and as the Manager of Inventory & Purchasing at Fielding Pharmaceutical from 2000 to 2004. Overall, they have held positions of increasing responsibility and has expertise in quality and compliance management.
Jen Buist attended Washington University in St. Louis, although the exact start and end years of their education there are unknown. It is not specified what degree they pursued or what field of study they focused on during their time at the university.
This person is not in any offices
Medvantx
Headquartered in San Diego, California, Medvantx is an innovative consumer medication management and delivery company committed to reducing costs and providing information to benefit patients, healthcare providers, payors, employers and manufacturers.Their state-of-the-art mail order pharmacy, operating in Sioux Falls, South Dakota, is licensedin all 50 states and serves as a full line mail order prescription drug and information provider to consumers. Their 35,000 square foot facility recently underwent major upgrades and now meets over 200 cGMP-level quality standards and can properly handle all pharmaceuticals requiring Cold Chain processing.Medvantx was recognized by Inc. Magazine in 2009 as the fastest growing privately held healthcare company in the country and 13th fastest overall.